Practice question

Answer the question and get instant feedback.

ModerateCardiologyAtherosclerotic Disease (Residual Risk)us-abimus-usmle-step-2

A 59-year-old with type 2 diabetes and ASCVD is on maximally tolerated statin, ezetimibe, and PCSK9 inhibitor with LDL 58 mg/dL. Triglycerides 260 mg/dL. Which therapy may reduce CV events?

Educational content. Not a substitute for clinical judgement or local policy.